Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02827448 · ClinicalTrials.gov registry record
Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 300
- Enrollment target
NCT02827448 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 300 participants.
The verdict
NCT02827448 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to test how well the NephroCheckTM Test, a noninvasive laboratory test performed on urine, predicts loss of kidney function in patients that have had a heart transplant or a Left Ventricular Assist Device (LVAD) or Total Artificial Heart (TAH) implanted.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02827448
The ClinicalTrials.gov registry entry for NCT02827448 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02827448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02827448 about?
NCT02827448 is a clinical study titled "Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies". The purpose of this study is to test how well the NephroCheckTM Test, a noninvasive laboratory test performed on urine, predicts loss of kidney function in patients that have had a heart transplant or a Left Ventricular Assist Device (LVAD) or Total Artificial Heart (TAH) implanted.
What is the current status of trial NCT02827448?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2015-11. Estimated completion is 2018-06.
Who is sponsoring clinical trial NCT02827448?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.